- Biological Products Analysis Service Primary Structure Analysis Service Therapeutics Characterization Service | Advanced Structural Charge Heterogeneity Analysis Service Biopharmaceutical Impurities Analysis Service
- Preclinical Drug Development Active Ingredients Identification and Screening Service Drug Target Analysis Service Biopharmaceuticals Characterization Service Targeted Drug Delivery Service | Precise and Efficacious Customized Drug Development and Optimize Service
- Thematic Analysis Service High-Throughout Gene Knockout Services Biopharmaceutical Stability Analysis Service PROTAC Drug Off-Target Protein Assessment Service Biosimilar Assessment Service Generic Peptide Pharmaceuticals Assessment Service Research on Media Development and Optimization Vaccine Quality Research and Testing Solutions Antibody Drug Analysis Service mRNA Drug Analysis Service Medical Device Analysis Service
- Proteomics Analysis Service Sample Preparation Service Protein Analysis Service Quantitative Proteomics Service Post-Translational Modifications Proteomics Service Proteomics Service of Different Sample Types Targeted Proteomics Service Peptidomics Analysis Service Proteomics Bioinformatic Analysis Service High-Throughout Proteomics Analysis Service for Gene Knockout Chemical Proteomics Analysis Service
- Metabolomics Analysis Service Untargeted Metabolomics Service Targeted Metabolomics Analysis Service High-Throughput Metabolomics Service After Gene Knockout Metabolomics Bioinformatic Analysis Service More Services
- Lipidomics Analysis Service Untargeted Lipidomics Analysis Service Targeted Lipidomics Analysis Service Exosome Lipidomics Service Lipidomics MALDI Imaging Service Oxylipidomics Service
- Multi-Omics Analysis Service Integrative Lipidomics-Proteomics Analysis Service Integrative Transcriptomics-Metabolomics Analysis Service Integrative Transcriptomics-Proteomics Analysis Service Integrative Transcriptomics-Lipidomics Analysis Service Integrative Metabolomics-16S rDNA Sequencing Analysis Service Integrative Proteomics-Metabolomics Analysis Service Integrative PTM-Metabolomics Analysis Transcriptome Sequencing (RNA-sequencing) Service Metatranscriptomics Sequencing Service Full-Length 16S/18S/ITS Sequencing Service Prokaryotic Transcriptomics Sequencing Service Eukaryotic Non-Ginseng Transcriptome Sequencing Service Eukaryotic Transcriptome Sequencing Service 16S/18S/ITS Amplicon Sequencing Service Exosomal Sequencing Service
- Single Cell Analysis Service Single Cell Sequencing Service Single Cell Mass Cytometry Analysis
- Bioinformatics
KEGG Pathway Enrichment Analysis Using KOBAS Software
Published: November 5, 2024
KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment analysis is a powerful bioinformatics tool extensively used in genomics and proteomics research to identify functional distributions within gene or protein sets. KOBAS software, known for its accuracy and efficiency in pathway annotation and enrichment, is a preferred tool for large-scale omics data analysis.
The KEGG database offers comprehensive information on biological pathways, including metabolic pathways, signaling cascades, disease mechanisms, and drug actions. Pathway enrichment analysis aims to annotate pathways within a gene or protein set, revealing significant biological changes under specific research conditions.
KOBAS (KEGG Orthology-Based Annotation System) software performs pathway enrichment analysis by leveraging species homology and functional annotations. Integrating data from KEGG and other annotation databases, KOBAS efficiently annotates and enriches genes and proteins across various omics datasets, including transcriptomic, genomic, and proteomic data.
KOBAS Software’s KEGG Pathway Enrichment Analysis Workflow
1. Gene Annotation
KOBAS begins with functional annotation of gene or protein sequences provided by users. Through homology-based comparisons with known genes, KOBAS accurately assigns functions to previously unannotated genes and maps them to relevant KEGG pathways.
2. Pathway Enrichment
Following annotation, KOBAS evaluates gene enrichment levels across pathways using statistical tests (e.g., hypergeometric distribution, Fisher’s exact test). Pathways significantly enriched in the gene set are identified, providing insights into their biological relevance.
3. Significance Testing
KOBAS performs significance testing and multiple test corrections (e.g., Benjamini-Hochberg) to control false positives, ensuring that enriched pathways reflect true biological significance rather than random variation.
4. Output and Visualization
KOBAS generates detailed pathway enrichment reports and visualizations, enabling users to interpret and further analyze their results.
Mechanisms of KEGG Pathway Enrichment in KOBAS
1. Gene Annotation Mechanism
KOBAS utilizes the KEGG Orthology (KO) system for gene annotation, which categorizes genes by functional similarity, allowing genes with similar biological functions to be grouped accordingly. This system helps KOBAS compare experimental gene data with a reference library to assign functional annotations.
2 Enrichment Significance Mechanism
KOBAS calculates pathway enrichment significance by statistical methods. Using hypergeometric or Fisher’s exact tests, KOBAS evaluates the probability of gene enrichment within each pathway. When pathway gene counts significantly exceed random expectations, these pathways are flagged as relevant. Multiple test corrections then ensure reliable results.
Application Scenarios for KOBAS in KEGG Pathway Enrichment Analysis
1. Disease Mechanism Research
Comparing pathway enrichment in differentially expressed genes across healthy and diseased states allows KOBAS to reveal disease-associated pathways, providing insights into underlying disease mechanisms.
2. Drug Mechanism Research
KOBAS aids in identifying pathways influenced by drugs, uncovering molecular drug mechanisms and supporting new drug development.
3. Environmental Stress Response
In plant and microbial research, KOBAS is used to assess pathway enrichment of differentially expressed genes under specific environmental stress, offering insights into organisms' adaptive responses.
Advantages and Limitations of KEGG Pathway Enrichment Using KOBAS
1. Advantages
(1) High Accuracy: KOBAS utilizes the KEGG and other annotation databases, allowing for precise gene function annotation
(2) Support for Multiple Species: KOBAS is compatible with multiple species, making it highly adaptable for cross-species pathway enrichment analysis.
(3) Efficient Data Processing: KOBAS handles large-scale omics datasets efficiently, especially for high-throughput sequencing data, offering rapid pathway annotation and enrichment analysis.
2. Limitations
(1) Dependency on Database Updates: KOBAS relies on up-to-date databases, such as KEGG, to ensure accurate analysis results, and outdated data may affect the precision of results.
(2) Limited Sensitivity for Low-Abundance Genes: KOBAS may be less effective at detecting enrichment in low-abundance genes, potentially missing certain biologically relevant pathways.
(3) High Computational Requirements: Large-scale data enrichment analysis in KOBAS requires significant computational resources, which may pose a challenge for researchers with limited access to such resources.
KEGG pathway enrichment analysis using KOBAS software offers a robust and efficient tool for investigating gene function and biological pathways, applicable to various omics data types. With continual improvements in database resources and analysis algorithms, KOBAS is set to play an increasingly valuable role in elucidating gene functions, understanding biological processes, and exploring disease mechanisms.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
KEGG Pathway Annotation and Enrichment Analysis Service
How to order?
